Specifically, in this late‐middle‐aged and older adult cohort enriched for AD risk, the expected unfavorable age‐related changes in neuroinflammation (IL‐6 and S100B), synaptic dysfunction (Ng), and neurodegeneration (α‐Syn) were attenuated in KL‐VSHET. This evidence concerns the gene IL6 and Alzheimer disease.